0001493152-21-003685.txt : 20210212 0001493152-21-003685.hdr.sgml : 20210212 20210212170028 ACCESSION NUMBER: 0001493152-21-003685 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KINGSLEY ALFRED D CENTRAL INDEX KEY: 0001229339 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 21629071 MAIL ADDRESS: STREET 1: 150 E 57TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc. CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: BIOTIME INC DATE OF NAME CHANGE: 19930328 5 1 ownership.xml X0306 5 2020-12-31 0 0 0 0000876343 Lineage Cell Therapeutics, Inc. LCTX 0001229339 KINGSLEY ALFRED D C/O LINEAGE CELL THERAPEUTICS 2173 SALK AVENUE, SUITE 200 CARLSBAD, CA 92008 1 0 0 0 Common Shares, no par value 2020-12-01 5 G 0 17500 D 5408445 D Common Shares, no par value 1043346 I By Corporation Common Shares, no par value 375351 I By LP During December 2020, Mr. Kingsley gifted a total of 17,500 common shares. Held by Greenbelt Corporation, of which Mr. Kingsley is an executive officer, director, and controlling shareholder. Mr. Kingsley disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest. Held by Greenway Partners, LP, of which Mr. Kingsley is the General Partner and has sole voting and dispositive control. /s/ Chase C. Leavitt, as Attorney-in-Fact 2021-02-12